Michael Didriksen PhD
Senior Director - Schizophrenia/Psychosis Biology Lead at Lundbeck A/S
Michael Didriksen holds a position as Senior Director - Schizophrenia/Psychosis Biology Lead at Lundbeck A/S. In this position, he is leading and coordinating preclinical research projects and bridging preclinical and clinical research within schizophrenia and psychosis in Lundbeck.
Michael Didriksen has been/are member of several international consortias, and have chaired national and international research projects including the IMI project NEWMEDS the H2020 project COSYN, the COST project MINDDS and the project BrainSeq a precompetitive consortium for brain genomics.
Michael Didriksen joined Lundbeck in 1994. During his time at Lundbeck he has held various positions as line and project manager in research and been member of late stage development project teams and strategic boards.
Michael Didriksen obtained his MSc degree and PhD in Psychopharmacology from the Royal Danish School of Pharmacy. In 2006 2007 he was visiting scientist in Prof. Marc Caron lab at Duke University.